Ten63 Therapeutics
Medical AI · Artificial Intelligence
$2.1Mlatest round · Venture round · Jan 2021 · 5 yr ago
1backers · SOSV
10+team · employees, estimated range
2019founded
Overview
Ten63 Therapeutics builds BEYOND, the world's first Large Quantum Chemistry Model — pairing generative chemistry at scale with quantum-accurate simulation (Superlearning) to design therapeutics for previously undruggable and under-drugged targets.
Funding and backers
Total raised
$2.1M
1 round on record
Latest round
$2.1M
Venture round · Jan 2021 · 5 yr ago
Team
11-50
employees, estimated range
Backers
1
SOSV
The money's age
Long since its last round
70 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2021 | $2.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Ten63 Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Marcel FrenkelExecutive Officer, DirectorSEC Form D
Mark HallenExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Orbis Medicines
backs Warp Sciences
backs Warp Sciences
backs Warp Sciences
backs Warp Sciences
backs Warp Sciences
Similar startupsby what they do, their industry and backers
Defining a new era in drug discovery where chemistry rewrites the rules of biology to engage any protein target.
Warp is the AI-driven U.S. chemistry CRO that turns AI-designed molecules into compounds drug discovery teams can test, in labs built for…
BioAscent is the leading provider of integrated drug discovery services, including compound management, chemistry, DMPK, biophysics and…
SIMPLIFYDRUGDISCOVERY. UNC at Chapel Hill – Machine Learning Via Web ApplicationBristol-Myers Squibb – Combinatorial Chemical Library…
PROSION Therapeutics is a drug development company that utilises cutting-edge technology to unlock so far undruggable targets and address…
Oral biologics, solved with intelligent chemistry. Powered by nGen, our discovery platform, we are pioneering a new modality: nCycle based…
Visa sponsorship
4
H-1B filings in 12 months
$155k
Median offered salary
0
Open roles in United States
Who they sponsor
Chemists
3
Bioengineers and biomedical engineers
1
In the register as Ten63 Therapeutics Inc., Durham, NC (+1 more)
Other sponsors in the same field
Eko 
Bexorg 
Prellis Biologics 
AnaBios
Alert me
US Department of Labor · latest filing May 28, 2026 · Visa details by country
Financials
Total raised
$2.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2021 | $2.1M | Details |
People
Marcel Frenkel
Executive Officer, Director
Mark Hallen
Executive Officer, Director
Jia Wei Xu
Director
Damien Petty
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
SOSVVia a fund
780 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Durham
United States
HQ
10-50 est. staff